Calcitonin gene-related peptide and adrenomedullin release in humans: Effects of exercise and hypoxia

Regulatory Peptides

Volumn 108, Issue 2-3, 2002, Pages 89-95

  Hasbak, Philip ^a,b   Lundby, Carsten ^c   Olsen, Niels Vidiendal ^c,d   Schifter, Søren ^b   Kanstrup, Inge Lis ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Adrenalin; Calcitonin; CGRP; Exercise; Humans; Hypoxia; Lactic acid; Noradrenaline

Indexed keywords

ADRENALIN; ADRENOMEDULLIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LACTIC ACID; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ALTITUDE DISEASE; ARTICLE; CALCITONIN BLOOD LEVEL; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME RELEASE; ENZYME SYNTHESIS; EXERCISE; FEMALE; HEART RATE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOXIA; LACTATE BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENOMEDULLIN; ADULT; ALTITUDE; ALTITUDE SICKNESS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; DOMPERIDONE; DOPAMINE ANTAGONISTS; EPINEPHRINE; EXERCISE; FEMALE; HEART RATE; HUMANS; LACTATES; MALE; NOREPINEPHRINE; PEPTIDES; REFERENCE VALUES; VASODILATION;

EID: 0037107382     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00129-5     Document Type: Article

References (45)

1. Muff R., Born W., Fischer J.A. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur. J. Endocrinol. 133:1995;17-20.
2. Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J.et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 304:1983;129-135.
3. Amara S.G., Arriza J.L., Leff S.E., Swanson L.W., Evans R.M., Rosenfeld M.G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 229:1985;1094-1097.
4. Wimalawansa S.J., Morris H.R., Etienne A., Blench I., Panico M., MacIntyre I. Isolation, purification and characterization of beta-hCGRP from human spinal cord. Biochem. Biophys. Res. Commun. 167:1990;993-1000.
5. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
6. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 313:1985;54-56.
7. Gennari C., Imbimbo B. Effects of prednisone and deflazacort on vertebral bone mass. Calcif. Tissue Int. 37:1985;592-593.
8. Brain S.D., Cambridge H. Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role. Gen. Pharmacol. 27:1996;607-611.
9. Schifter S., Breum L., Niclasen B., Vollmer-Larsen A., Rasmussen H.S., Graff-Larsen O. Calcitonin gene-related peptide during exercise and training. Horm. Metab. Res. 27:1995;473-475.
10. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28:1990;183-187.
11. Lind H., Brudin L., Lindholm L., Edvinsson L. Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man. Clin. Physiol. 16:1996;73-82.
12. Franco-Cereceda A., Lundberg J.M. Capsazepine inhibits low pH-and lactic acid-evoked release of calcitonin gene-related peptide from sensory nerves in guinea-pig heart. Eur. J. Pharmacol. 221:1992;183-184.
13. Wang X., Fiscus R.R. Lactic acid potentiates bradykinin-and low-pH-induced release of CGRP from rat spinal cord slices. Am. J. Physiol. 273:1997;E92-E98.
14. Morganti A., Giussani M., Sala C., Gazzano G., Marana I., Pierini A.et al. Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects. J. Hypertens. 13:1995;859-865.
15. Keith I.M., Ekman R. Dynamic aspects of regulatory lung peptides in chronic hypoxic pulmonary hypertension. Exp. Lung Res. 18:1992;205-224.
16. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H.et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
17. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:2000;138-167.
18. (2+)-sensitivity in pig coronary arterial smooth muscle. Biochem. Biophys. Res. Commun. 212:1995;572-579.
19. Tanaka M., Kitamura K., Ishizaka Y., Ishiyama Y., Kato J., Kangawa K.et al. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern. Med. 34:1995;728-733.
20. Morimoto A., Nishikimi T., Takaki H., Okano Y., Matsuoka H., Takishita S.et al. Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction. Clin. Exp. Pharmacol. Physiol. 24:1997;315-320.
21. Nishikimi T., Morimoto A., Ishikawa K., Saito Y., Kangawa K., Matsuo H.et al. Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects. Clin. Exp. Hypertens. 19:1997;503-518.
22. Toepfer M., Hartmann G., Schlosshauer M., Hautmann H., Tschop M., Fischer R.et al. Adrenomedullin: a player at high altitude? Chest. 113:1998;1428.
23. 2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 252:1990;586-592.
24. 2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int. 43:1993;197-204.
25. 2-receptors and effect of oxygen supplementation. Clin. Sci. (Lond.). 101:2001;377-383.
26. Morier-Teissier E., Rips R. Catecholamine metabolite measurements in mouse brain using high-performance liquid chromatography and electrochemical detection: comparison of a one-column technique with a two-column switching technique. Methods Enzymol. 142:1987;535-549.
27. Schifter S. Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassay. Peptides. 12:1991;365-369.
28. Schifter S. A new highly sensitive radioimmunoassay for human calcitonin useful for physiological studies. Clin. Chim. Acta. 215:1993;99-109.
29. Tippins J.R. CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. J. Hypertens., Suppl. 4:1986;S102-S105.
30. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation. 97:1998;1062-1070.
31. Ihara T., Ikeda U., Tate Y., Ishibashi S., Shimada K. Positive inotropic effects of adrenomedullin on rat papillary muscle. Eur. J. Pharmacol. 390:2000;167-172.
32. Saetrum, Opgaard O., Hasbak P., de Vries R., Saxena P.R., Edvinsson L. Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. Eur. J. Pharmacol. 397:2000;373-382.
33. Wadsworth R.M. Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol. Sci. 15:1994;47-53.
34. Mannan M.M., Springall D.R., Enard C., Moradoghli-Haftvani A., Eddahibi S., Adnot S.et al. Decreased endothelium-dependent pulmonary vasodilator effect of calcitonin gene-related peptide in hypoxic rats contrasts with increased binding sites. Eur. Respir. J. 8:1995;2029-2037.
35. Cormier-Regard S., Nguyen S.V., Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273:1998;17787-17792.
36. Nakayama M., Takahashi K., Murakami O., Shirato K., Shibahara S. Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides. 20:1999;769-772.
37. Hofbauer K.H., Jensen B.L., Kurtz A., Sandner P. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R513-R519.
38. Kitamuro T., Takahashi K., Nakayama M., Murakami O., Hida W., Shirato K.et al. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. J. Neurochem. 75:2000;1826-1833.
39. Qing X., Svaren J., Keith I.M. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L547-L554.
40. Shimokubo T., Sakata J., Kitamura K., Kangawa K., Matsuo H., Eto T. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci. 57:1995;1771-1779.
41. Wittenberg B.A., Wittenberg J.B. Transport of oxygen in muscle. Annu. Rev. Physiol. 51:1989;857-878.
42. Juul R., Edvinsson L., Gisvold S.E., Ekman R., Brubakk A.O., Fredriksen T.A. Calcitonin gene-related peptide-LI in subarachnoid haemorrhage in man. Signs of activation of the trigemino-cerebrovascular system? Br. J. Neurosurg. 4:1990;171-179.
43. Valdemarsson S., Edvinsson L., Ekman R., Hedner P., Sjoholm A. Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors. J. Intern. Med. 230:1991;325-331.
44. Trasforini G., Margutti A., Valentini A., Ambrosio M.R., Bondanelli M., Rossi R.et al. Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: effects of administration of epinephrine and norepinephrine in healthy man. Regul. Pept. 63:1996;57-61.
45. Tidgren B., Theodorsson E., Hjemdahl P. Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans. Clin. Physiol. 11:1991;9-19.